Literature DB >> 11596779

Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke.

Z Szolnoki1, F Somogyvári, A Kondacs, M Szabó, L Fodor.   

Abstract

OBJECTIVE: The Leiden V mutation, which causes activated protein C resistance and thrombophilia, has been found to be a risk factor for venous thrombosis. The angiotensin converting enzyme (ACE) D allele indirectly exerts an unfavourable effect on the vasoregulatory system. In this study, the frequency of these mutations was analysed in different subtypes of ischaemic stroke. METHOD AND MATERIAL: According to the clinical and radiological features 664 Hungarian patients who had suffered acute ischaemic stroke were divided into 3 subtypes: small and large vessel infarcts and a mixed type. In all 664 patients, the Leiden V mutation and ACE I/D polymorphism were examined by means of the PCR technique. The frequencies of the different genotypes for the Leiden V mutation and ACE I/D polymorphism in the 3 subgroups of stroke were compared with 199 stroke-free control subjects whose MRI findings were normal.
RESULTS: No significant associations were found between the overall group of cerebral infarctions and the Leiden V, ACE I/D and ACE D/D genotypes. The ACE D/D genotype was significantly more common in the patients with small deep infarcts (40.3%; p < 0.0005; OR 2.31, 95% CI 1.49-3.57) than in the control group (22.6%). The Leiden V mutation was significantly more common in patients with large infarcts (13.6%; p < 0.025; OR 2.25, CI 1.16-4.34) than in the stroke-free control subjects (6.5%).
CONCLUSIONS: The ACE D/D genotype possibly contributes to the occurrence of small-vessel infarcts rather than large vessel infarcts. The Leiden V mutation might predispose to large brain infarcts. Neither the Leiden V factor nor the ACE D/D genotype has been proved to be a risk factor for ischaemic stroke as a whole.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596779     DOI: 10.1007/s004150170090

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  4 in total

1.  Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke.

Authors:  Z Szolnoki; F Somogyvári; A Kondacs; M Szabó; L Fodor; J Bene; B Melegh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 2.  Screening for hypercoagulable syndromes following stroke.

Authors:  Cheryl Bushnell; Larry B Goldstein
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

3.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

4.  The Interaction of Apolipoprotein E and Angiotensin I-Converting Enzyme Dna Polymorphisms with Hypertension on Early Ischemic Stroke Risk.

Authors:  Sanja Stankovic; Aleksandra Stankovic; Milika Asanin; Zagorka Jovanovic-Markovic; Dragan Alavantic; Nada Majkic-Singh
Journal:  EJIFCC       Date:  2010-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.